About Boehringer Ingelheim
The pharmaceutical company Boehringer Ingelheim was founded in 1885 by Albert Boehringer (1861-1939) in Ingelheim am Rhein. Boehringer Ingelheim is one of the pharmaceutical industry’s top 20 companies. Day by day, some 50,000 employees create value through innovation for the three business areas human pharmaceuticals, animal health and biopharmaceutical contract manufacturing.
A leader in respiratory disease
Boehringer Ingelheim has over 90 years of heritage in respiratory disease. Since 1921 we have emerged as a leader in this disease area, having launched several treatments in a range of respiratory conditions including asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF) and lung cancer. Our focus is on improving the quality of life of patients suffering from debilitating respiratory diseases and enabling them to maintain a more independent life.
AsthmaXchange is an online educational resource for healthcare professionals, providing interactive e-learning resources and practical tools on the diagnosis, treatment and management of asthma.
Think Act Breathe
Think, Act, Breathe is for patients and healthcare professionals. It aims to help identify the approximately 1 in 2 people with asthma who still experience symptoms despite taking current treatments and are at increased risk of potentially life threatening asthma exacerbations.